Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

Seven business leaders with ties to the D.C. area have joined Forbes list of global billionaires for the first time ever. The ...

Healthcare pioneer Laura Shawver, Ph.D. appointed Chair of the Board and industry veteran Roy Baynes M.D., Ph.D. appointed as independent, non-exe ...

The richest woman of all is Walmart heir Alice Walton, whose fortune stands at an estimated $101 billion. She reclaims the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Ricky Martin is returning to football, just over a year since he left his powerful position at Stoke City. Martin, who was ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Friday - Summit Therapeutics plc (NASDAQ:SMMT) stock received a new Overweight rating from Cantor Fitzgerald, signaling a positive outlook from the firm. The coverage initiation by Cantor Fitzgerald ...

United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United Therapeutics in a ...